Richard P. Shea
Independent DirectorMr. Richard P. Shea, also known as Rick, serves as an Independent Director of Synlogic, Inc. since August 28, 2017. He served as Chief Financial Officer of Pillar Biosciences Inc. He served as the Chief Financial Officer, Principal Accounting Officer and Treasurer of Syndax Pharmaceuticals, Inc. since February 13, 2017 until July 13, 2020. Mr. Shea served as the Chief Financial Officer and Senior Vice President of Finance at Momenta Pharmaceuticals Inc. from October 2003 to November 28, 2016 and from August 15, 2007 to November 28, 2016 respectively and also served as its Treasurer until November 28, 2016. Mr. Shea served as Vice President of Momenta Pharmaceuticals Inc. from October 2003 to August 15, 2007. From April 2002 to April 2003, Mr. Shea served as Chief Operating Officer and Chief Financial Officer of Variagenics Inc. (a pharmacogenomics company) and Treasurer since March 2000. From March 2000 to April 2002, he served as Variagenic's Chief Financial Officer and from February 1999 to March 2000, he served as its Vice President, Finance and Administration. While at Variagenics, he was responsible for finance, legal, investor relations, human resources and operations. From April 1997 to January 1999, Mr. Shea worked at Genetics Institute, where he served as Vice President of Finance and from October 1992 to April 1997 he served as its Controller and served as Senior Manager at PricewaterhouseCoopers LLP in Boston and Copenhagen, primarily serving clients in the high technology and manufacturing sectors. He served as an Independent Director at Syndax Pharmaceuticals, Inc. from January 23, 2014 to February 13, 2017. Mr. Shea is a Certified Public Accountant and holds A.B. degree from Princeton University and his M.B.A. in Public Management Program with High Honors from Boston University.
Positions
- Company NameSynlogic, Inc.Stock CodeSYBXPositionIndependent DirectorColleagues
